Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2014 (2014), Article ID 473503, 7 pages
http://dx.doi.org/10.1155/2014/473503
Research Article

A Novel Approach for the Enumeration of Peripheral Blood Stem Cells Suitable for Transplantation

Stem Cell Section, Department of CML and Blood Bank, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi Arabia

Received 24 June 2014; Accepted 23 July 2014; Published 5 August 2014

Academic Editor: P. Burra

Copyright © 2014 Winston Costa Pereira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Goldman, K. H. Th'ng, D. S. Park, A. S. Spiers, R. M. Lowenthal, and T. Ruutu, “Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation,” British Journal of Haematology, vol. 40, no. 2, pp. 185–195, 1978. View at Google Scholar · View at Scopus
  2. A. Trumpp, M. Essers, and A. Wilson, “Awakening dormant haematopoietic stem cells,” Nature Reviews Immunology, vol. 10, no. 3, pp. 201–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Kondo, A. J. Wagers, M. G. Manz et al., “Biology of hematopoietic stem cells and progenitors: implications for clinical application,” Annual Review of Immunology, vol. 21, pp. 759–806, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. E. Bishop, L. D. K. Buttery, and J. M. Polak, “Haematopoietic stem cells,” Journal of Pathology, vol. 197, no. 4, pp. 430–440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Shizuru, R. S. Negrin, and I. L. Weissman, “Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system,” Annual Review of Medicine, vol. 56, pp. 509–538, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. G. Hawley, “Progress toward vector design for hematopoietic stem cell gene therapy,” Current Gene Therapy, vol. 1, no. 1, pp. 1–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Siena, R. Schiavo, P. Pedrazzoli, and C. Carlo-Stella, “Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy,” Journal of Clinical Oncology, vol. 18, no. 6, pp. 1360–1377, 2000. View at Google Scholar · View at Scopus
  8. L. B. To, D. N. Haylock, P. J. Simmons, and C. A. Juttner, “The biology and clinical uses of blood stem cells,” Blood, vol. 89, no. 7, pp. 2233–2258, 1997. View at Google Scholar · View at Scopus
  9. D. R. Sutherland, L. Anderson, M. Keeney, R. Nayar, and I. Chin-Yee, “The ISHAGE guidelines for CD34+ cell determination by flow cytometry,” Journal of Hematotherapy and Stem Cell Research, vol. 5, no. 3, pp. 213–226, 1996. View at Google Scholar · View at Scopus
  10. S. Massberg and U. H. von Andrian, “Novel trafficking routes for hematopoietic stem and progenitor cells,” Annals of the New York Academy of Sciences, vol. 1176, pp. 87–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Spradling, D. Drummond-Barbosa, and T. Kai, “Stem cells find their niche,” Nature, vol. 414, no. 6859, pp. 98–104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Petit, M. Szyper-Kravitz, A. Nagler et al., “G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4,” Nature Immunology, vol. 3, no. 7, pp. 687–694, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. W. I. Bensinger, T. H. Price, D. C. Dale et al., “The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis,” Blood, vol. 81, no. 7, pp. 1883–1889, 1993. View at Google Scholar · View at Scopus
  14. P. Anderlini, D. Przepiorka, J. Lauppe et al., “Collection of peripheral blood stem cells from normal donors 60 years of age or older,” British Journal of Haematology, vol. 97, no. 2, pp. 485–487, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Lapidot, A. Dar, and O. Kollet, “How do stem cells find their way home?” Blood, vol. 106, no. 6, pp. 1901–1910, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Baldomero, M. Gratwohl, A. Gratwohl et al., “The EBMT activity survey 2009: trends over the past 5 years,” Bone Marrow Transplantation, vol. 46, no. 4, pp. 485–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Gratwohl and H. Baldomero, “Trends of hematopoietic stem cell transplantation in the third millennium,” Current Opinion in Hematology, vol. 16, no. 6, pp. 420–426, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Cohen and A. Nagler, “Umbilical cord blood transplantation—how, when and for whom?” Blood Reviews, vol. 18, no. 3, pp. 167–179, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Bensinger, F. Appelbaum, S. Rowley et al., “Factors that influence collection and engraftment of autologous peripheral-blood stem cells,” Journal of Clinical Oncology, vol. 13, no. 10, pp. 2547–2555, 1995. View at Google Scholar · View at Scopus
  20. K. R. Desikan, G. Tricot, N. C. Munshi et al., “Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone,” British Journal of Haematology, vol. 112, no. 1, pp. 242–247, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. C. H. Weaver, B. Hazelton, R. Birch et al., “An analysis of engraftment kinetics as a function of the CD34+ content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy,” Blood, vol. 86, no. 10, pp. 3961–3969, 1995. View at Google Scholar · View at Scopus
  22. N. Ketterer, G. Salles, M. Raba et al., “High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation,” Blood, vol. 91, no. 9, pp. 3148–3155, 1998. View at Google Scholar · View at Scopus
  23. S. Giralt, E. A. Stadtmauer, J. L. Harousseau et al., “International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100),” Leukemia, vol. 23, no. 10, pp. 1904–1912, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Sancho, M. Morgades, J. R. Grifols et al., “Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+ cell count to guide pre-emptive or immediate rescue mobilization,” Cytotherapy, vol. 14, no. 7, pp. 823–829, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Fu and J. Liesveld, “Mobilization of hematopoietic stem cells,” Blood Reviews, vol. 14, no. 4, pp. 205–218, 2000. View at Publisher · View at Google Scholar · View at Scopus